Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.6 AUD | -.--% | -5.04% | -.--% |
24/04 | Medlab Clinical Limited Reports Earnings Results for the Full Year Ended June 30, 2023 | CI |
29/02 | Medlab Clinical Limited Announces Change of Share Registry | CI |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Research, Development and Pre-commercialisation
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -30.44% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -30.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kerem Kaya
DFI | Director of Finance/CFO | - | 13/21/13 |
Jeremy Henson
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
David A. Rutolo
CTO | Chief Tech/Sci/R&D Officer | - | 22/15/22 |
Laine Yonker
IRC | Investor Relations Contact | - | - |
Tony Potter
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 06/23/06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,283,502 | 1,284,597 ( 56.26 %) | 0 | 56.26 % |
Company contact information
Sector
Sales per Business
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 9.97M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- MDC Stock
- Company Medlab Clinical Limited